Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss...

Oct 21, 2024 · Are Ozempic, Wegovy and other approved drugs safe and effective for older adults? Here's what to know about new weight loss drugs

Aug 27, 2024 · Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand...

Nov 16, 2024 · Competition is on the way: Dozens of experimental new weight-loss medications are in development as biotech companies race to get a slice of a market forecast to be worth $100 billion. Some...

Jun 5, 2024 · Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead...

Jan 20, 2025 · Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...

Nov 9, 2023 · A new weight loss drug has been approved that promises to be the most effective medication yet. Zepbound belongs to a new class of medications, alongside Ozempic and Wegovy, that have skyrocketed...

Jan 24, 2025 · The new drug, amycretin, similar to the company's blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, provided weight loss of up to 22% in early-stage clinical trials.

Dec 5, 2024 · Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss.